Novartis (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Novartis" in Malay language version.

refsWebsite

Global rank Malay rank

10web.archive.org

1^st place

2novartis.com

low place

2nibr.com

low place

1seattletimes.com

519^th place

2,724^th place

1proclinical.com

low place

1contractpharma.com

low place

1nytimes.com

7^th place

44^th place

1thefreelibrary.com

518^th place

1,932^nd place

1archive.is

87^th place

43^rd place

1efpia.eu

low place

1ifpma.org

low place

1phrma.org

low place

1archive.today

14^th place

79^th place

1fiercepharma.com

low place

1thehindubusinessline.com

724^th place

5,051^st place

1indiatimes.com

17^th place

108^th place

1boston.com

310^th place

2,000^th place

1doi.org

2^nd place

8^th place

1nih.gov

4^th place

14^th place

1innomed-predtox.com

low place

1europa.eu

68^th place

197^th place

1reuters.com

49^th place

98^th place

archive.is

"The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). m/s. 49. Diarkibkan daripada yang asal (PDF) pada 16 September 2008. Dicapai pada 25 Ogos 2008.

archive.today

Staff, EP Vantage. 25 April 2012 Novartis on track to become world's biggest drug maker

boston.com

Ross, Casey (2010-10-27). "Novartis doubles plan for Cambridge". The Boston Globe. Diarkibkan daripada yang asal pada 2012-11-03. Dicapai pada 2010-10-31.

contractpharma.com

"Top 25 Pharma & BioPharma in 2022 | Contract Pharma". www.contractpharma.com.

doi.org

Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". Dalam Mendrick, Donna L.; Mattes, William B. (penyunting). Essential Concepts in Toxicogenomics. Methods in Molecular Biology. 460. m/s. 221–238. doi:10.1007/978-1-60327-048-9_11. ISBN 978-1-58829-638-2. PMID 18449490.

efpia.eu

"The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). m/s. 49. Diarkibkan daripada yang asal (PDF) pada 16 September 2008. Dicapai pada 25 Ogos 2008.

europa.eu

imi.europa.eu

Innovative Medicines Initiative, penyunting (2008), "IMI-GB-018v2-24042008-CallTopics.pdf", IMI 1st Call 2008: Information Package (ZIP archive), European Commission, diarkibkan daripada yang asal (PDF) pada 24 September 2015, dicapai pada 16 Januari 2012

fiercepharma.com

"Novartis slashing thousands more jobs in global reorganization, shifting many to India". FiercePharma.

ifpma.org

IFPMA Member List Diarkibkan 7 Februari 2014 di Wayback Machine

indiatimes.com

articles.economictimes.indiatimes.com

"Novartis India strikes 8.7 lakh square feet office space deal in Hyderabad". timesofindia-economictimes.

innomed-predtox.com

InnoMed PredTox Member Organizations (web page), InnoMed, diarkibkan daripada yang asal pada 2008-09-26, dicapai pada 2008-08-25

nibr.com

Novartis Institutes for BioMedical Research Official SIte Diarkibkan 2 Mei 2014 di Wayback Machine
Innovation for the developing world Diarkibkan 9 Februari 2014 di Wayback Machine

nih.gov

pubmed.ncbi.nlm.nih.gov

Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". Dalam Mendrick, Donna L.; Mattes, William B. (penyunting). Essential Concepts in Toxicogenomics. Methods in Molecular Biology. 460. m/s. 221–238. doi:10.1007/978-1-60327-048-9_11. ISBN 978-1-58829-638-2. PMID 18449490.

novartis.com

"Annual Report and 20-F Archive - Novartis" (PDF). Novartis. Diarkibkan daripada yang asal (PDF) pada 2013-02-28. Dicapai pada 6 February 2018.
"Company history", corporate website, Novartis, novartis.com, diarkibkan daripada yang asal pada 30 December 2010

nytimes.com

Andrew Ross Sorkin for The New York Times. 3 December 1999 AstraZeneca and Novartis To Shed Agricultural Units Accessed 27 May 2013

phrma.org

PhRMA Member List Diarkibkan 6 Oktober 2013 di Wayback Machine

proclinical.com

https://www.proclinical.com/blogs/2022-6/who-are-the-top-10-pharma-companies-in-the-world-2022

reuters.com

"Novartis, U.S. partner plan remote trials to boost participation". Reuters. 2018-03-07. Dicapai pada 2018-03-15.

seattletimes.com

"Novartis 1Q profit jumps 12 percent as heart drug sales soar". Business. The Seattle Times. Associated Press. 19 April 2018. Dicapai pada 2018-04-20.

thefreelibrary.com

Staff, PRNewsWire. 13 November 2000. Syngenta Begins Trading on the New York Stock Exchange Diarkibkan 2015-06-30 di Wayback Machine Accessed 27 May 2013.

thehindubusinessline.com

PT Jyothi Datta. "Novartis consolidates global services operations at Hyderabad centre". The Hindu Business Line.

web.archive.org

Staff, PRNewsWire. 13 November 2000. Syngenta Begins Trading on the New York Stock Exchange Diarkibkan 2015-06-30 di Wayback Machine Accessed 27 May 2013.
IFPMA Member List Diarkibkan 7 Februari 2014 di Wayback Machine
PhRMA Member List Diarkibkan 6 Oktober 2013 di Wayback Machine
"Annual Report and 20-F Archive - Novartis" (PDF). Novartis. Diarkibkan daripada yang asal (PDF) pada 2013-02-28. Dicapai pada 6 February 2018.
"Company history", corporate website, Novartis, novartis.com, diarkibkan daripada yang asal pada 30 December 2010
Ross, Casey (2010-10-27). "Novartis doubles plan for Cambridge". The Boston Globe. Diarkibkan daripada yang asal pada 2012-11-03. Dicapai pada 2010-10-31.
Novartis Institutes for BioMedical Research Official SIte Diarkibkan 2 Mei 2014 di Wayback Machine
Innovation for the developing world Diarkibkan 9 Februari 2014 di Wayback Machine
InnoMed PredTox Member Organizations (web page), InnoMed, diarkibkan daripada yang asal pada 2008-09-26, dicapai pada 2008-08-25
Innovative Medicines Initiative, penyunting (2008), "IMI-GB-018v2-24042008-CallTopics.pdf", IMI 1st Call 2008: Information Package (ZIP archive), European Commission, diarkibkan daripada yang asal (PDF) pada 24 September 2015, dicapai pada 16 Januari 2012